Timeline
Pharma
Tern investee Talking Medicines launches Intent to Prescribe tool
Oxford Nanopore wins injunction against MGI Tech in Europe
Avacta hits clinical proof of mechanism for AVA6103
Health & Bio Today: GSK seals up to $750m deal for Chimagen T cell-engager, Imaging Biometrics
ImmuPharma files international patent for P140 precision medicine approach
Imaging Biometrics signs regional health system for brain tumor imaging
GSK to acquire T cell-engager from Chimagen for up to $750m
Fusion Antibodies swings to narrower loss as margins jump
GSK's Ris-Rez cuts death risk 54% in lung cancer trial
AstraZeneca's SERENA-4 trial misses main goal in breast cancer study
Wellnex Life completes sale of Pain Away business
Integrated Diagnostics Holdings revenue jumps in H1
One Health Group keeps hub build on track for spring 2027 opening
Genus profit jumps 35% and unveils £60m buyback
Defence Holdings advances MoD delivery and expands product pipeline
Genedrive extends Welsh NICU testing service into 2027
GSK wins Japan approval for prefilled Shingrix syringe
Personal Group extends Simplyhealth partnership, opens Hapi to new clients
Health & Bio Today: Inspiration Healthcare neonatal unit surges, Cambridge Nutritional Sciences, OptiBiotix, Novacyt, Genflow Biosciences
AstraZeneca's Imfinzi combo extends survival in lung cancer trial
Cambridge Nutritional Sciences says its ready to turn potential into growth
Genflow hits primary endpoint in dog longevity trial
Novacyt secures IVDR certification for DPYD assay
Inspiration Healthcare guides slightly ahead as core SLE unit surges
Health & Bio Today: Spire agrees £1.03bn takeover, Futura Medical, MedPal AI, Incanthera, Ondine Biomedical, AstraZeneca, 4basebio
MedPal AI shares soar after August run rate update
4basebio expands DNA manufacturing for personalised medicine
Incanthera signs exclusive cream supply deal with LED skincare maker iSmart
Ondine's Steriwave piloted at Mexico's largest private hospital network
The Morning Brief: Spire Healthcare agrees £1.03bn takeover, Grainger, Ashmore, IQE
Spire Healthcare agrees £1.03bn takeover by Toscafund-led consortium
AstraZeneca wins US approval for Etcamah in breast cancer
Health & Bio Today: Futura Medical launches formal sale process alongside £1.6m raise, Renalytix, Solvonis Therapeutics
OptiBiotix's SlimBiome launches in new Holland & Barrett range
Truetide's Paraytec advances sepsis test as Gyrometric completes bearing project
Health & Bio Today: Futura Medical narrows loss, AstraZeneca, Wellnex Life, Novacyt, Renalytix, GSK, Ondine Biomedical
FDA clears Mounjaro for heart protection, MedPal flags market boost
AstraZeneca: Enhertu wins EU approval for first-line HER2-positive breast cancer
Renalytix signs Quest Diagnostics deal for kidney test
Ondine's nasal therapy hits primary endpoint in Phase 3 study
The Early Brief: Vodafone brings in OXG fibre partner, Bodycote, Bunzl, AstraZeneca, Capricorn Energy, GSK, Frasers Group, Transense
Renalytix raises £9.5m to fund testing collaboration
AstraZeneca completes $1.5bn Zegfrovy licence deal with Dizal
AstraZeneca's Tagrisso-Orpathys combo hits goal in first-line lung cancer trial
GSK flu vaccine moves to Phase III after strong Phase II data
Shield Therapeutics takes full US control of ACCRUFeR
hVIVO buys CRS Berlin in earnings-accretive deal
AstraZeneca's Tezspire hits primary endpoints in esophagitis trial
Health & Bio Today: Faron's cash pile doubles ahead of Phase 2b MDS trial, 4basebio, Eden Research
Companies in Pharma
- AstraZeneca LSE:AZN
- GSK GSK
- Bsf Enterprise BSFA
- Futura Medical FUM
- Solvonis Therapeutics SVNS
- Eco Animal Health AIM:EAH
- Novo Nordisk NVO
- Thalia Therapeutics LSE:THAT
- Beximco Pharmaceuticals LSE:BXP
- Nuformix LSE:NFX
- Eli Lilly LLY
- Hikma Pharmaceuticals LSE:HIK
- Novo Nordisk A/S 0QIU
- Avere Therapeutics Nasdaq:AVRX
- Kailera Nasdaq:KLRA